CMS Participation Deadline: March 18, 2026
The written comment period has come to an end, but there is still time to register for a Roundtable or Town Hall.
March 19th, 2026: Deadline to registration for CMS Roundtable Events and Townhall Meeting participation.
See below for the full registration and participation timeline as well as the drugs selected for negotiation.
Register Now for a Roundtable Event
DEADLINE: March 18, 2026
The roundtable events will be held April 6 – April 17, 2026. Registration closes on March 18, 2026.
Monday, April 6
- Anoro Ellipta | (Respiratory): 11 a.m. – 1 p.m. ET | Register Now
- Biktarvy | (HIV): 2:30 – 4:30 p.m. ET | Register Now
Wednesday, April 8
- Botox; Botox Cosmetic | (Neurology/Aesthetics): 11 a.m. – 1 p.m. ET | Register Now
- Cimzia | (Rheumatology/Autoimmune): 2:30 – 4:30 p.m. ET | Register Now
Thursday, April 9
- Cosentyx | (Rheumatology/Autoimmune): 11 a.m. – 1 p.m. ET | Register Now
- Entyvio | (Rheumatology/Autoimmune): 2:30 – 4:30 p.m. ET | Register Now
Friday, April 10
- Erleada | (Oncology-Prostate): 12 – 2 p.m. ET | Register Now
Monday, April 13
- Kisqali | (Oncology-Breast): 11 a.m. – 1 p.m. ET | Register Now
- Lenvima | (Oncology-Thyroid): 2:30 – 4:30 p.m. ET | Register Now
Tuesday, April 14
- Orencia (Rheumatology/Autoimmune): 11 a.m. – 1 p.m. ET | Register Now
- Rexulti | (Mental Health): 2:30 – 4:30 p.m. ET | Register Now
Wednesday, April 15
- Trulicity | (Diabetes): 11 a.m. – 1 p.m. ET | Register Now
- Verzenio | (Oncology-Breast): 2:30 – 4:30 p.m. ET | Register Now
Thursday, April 16
- Xeljanz; Xeljanz XR (Rheumatology/Autoimmune): 11 a.m. – 1 p.m. ET | Register Now
- Xolair | (Respiratory): 2:30 – 4:30 p.m. ET | Register Now
Friday, April 17
- Tradjenta | (Diabetes): 12 – 2 p.m. ET | Register Now
Learn How Patient Voices Fit into the Negotiation Process
Medicare drug price negotiations are happening now—and patient experience evidence is required by law. Our upcoming patient-focused webinars walk you through what’s happening, what’s at stake, and how to share your story in a way CMS must consider.
